HOME >> BIOLOGY >> NEWS
Protein biomarkers accurately and quickly diagnose ALS, find Pittsburgh researchers

MILAN, Italy, Nov. 17 Detection of protein abnormalities in cerebrospinal fluid (CSF) of patients with amyotrophic lateral sclerosis (ALS) may allow physicians to more rapidly diagnose and better monitor drug efficacy in clinical trials for the disease, according to a novel study presented by a University of Pittsburgh researcher in Milan, Italy, today.

These findings may lead to the first test for early stage ALS, also know as Lou Gehrig's disease.

The study, presented by Robert Bowser, Ph.D., of the University of Pittsburgh School of Medicine at the 11th annual meeting of the International Alliance of ALS/MND Associations and 14th International Symposium on ALS/MND, identified ALS-specific biomarkers by protein profiling of cerebrospinal fluid from 25 ALS patients and 35 control subjects.

"There are no known diagnostic biomarkers for ALS and no sensitive methods to determine whether a particular drug is working in an ALS patient, nor any way to best test drug combinations for effectiveness," said Dr. Bowser, who is associate professor of pathology and director of the ALS Tissue Bank at the University of Pittsburgh School of Medicine. "A panel of biomarkers would not only be useful in a more rapid diagnosis of ALS, but also would be a valuable tool to evaluate drug efficacy in clinical trials. Protein profiling may also identify biochemical pathways leading to cell death and new therapeutic targets."

CSF samples were obtained from recently diagnosed ALS patients and control subjects who did not have ALS. Some control subjects had no neurologic symptoms, while others had neurological diseases (including four with peripheral neuropathies, one with myopathy, one with probable Alzheimer's, one with demyelinating disorder, one with meningitis and one with autoimmune sensory motor axonopathy). CSF was used because it is in close contact with motor neurons and brain cells called glia affected by ALS and therefore may harbor high concent
'"/>

Contact: Frank Raczkiewicz
RaczkiewiczFA@upmc.edu
412-624-2607
University of Pittsburgh Medical Center
17-Nov-2003


Page: 1 2

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein controls acid in cells by direct detection of volume changes, study finds
9. Protein believed to control formation of memory identified by Scripps & UCSD scientists
10. Protein stops blood-vessel growth, holds promise as cancer therapy
11. Proteins transform DNA into molecular velcro

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/13/2019)... MOUNTAIN VIEW, Calif. (PRWEB) , ... March 13, 2019 , ... ... for up to 45 percent of the world’s population. One billion ... person's breathing is interrupted during sleep - more than 80 percent of whom go ...
(Date:3/12/2019)... (PRWEB) , ... March 12, 2019 , ... ... strong multi-factor authentication and combined technology all-in-one smart cards, announced today the launch ... strong authentication: the Fingerprint Biometric and Dynamic CVV Payment cards. These advanced technologies ...
(Date:3/9/2019)... (PRWEB) , ... March 07, 2019 , ... ... and infectious disease diagnostics and automation – is pleased to announce the launch ... control resource giving customers access to lot-specific information, including pattern images for AESQC ...
Breaking Biology News(10 mins):
(Date:3/9/2019)... ... March 08, 2019 , ... ... planning, announced the release of their Best Online Master's in Biotechnology Programs ... on curriculum quality, program flexibility, affordability, and graduate outcomes. , In addition ...
(Date:3/4/2019)... ... March 04, 2019 , ... Stay on top of current hot topics through free webinars ... webinars is free, so be sure to register today to save your place! Participate in ... our upcoming webinars: , CLINICAL TRIALS, , March 20 – Implementing ...
(Date:2/26/2019)... (PRWEB) , ... February 26, 2019 , ... ... 2012 when Visikol Co-Founder Dr. Thomas Villani developed the Visikol® tissue clearing technology ... and has since transitioned from a products focused company to primarily a services ...
(Date:2/22/2019)... ... 2019 , ... Ocean Tomo Transactions, LLC will auction a ... patents in lot 92 relate to innovation for verifying human users ... users and computers through exploiting the fundamental differences between computer-based vision and human ...
Breaking Biology Technology:
Cached News: